NCT06906289 Resumption of Enteral Feeding After Bowel Anastomosis
| NCT ID | NCT06906289 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Khyber Teaching Hospital |
| Condition | Enhanced Recovery After Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 204 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 204 participants in total. It began in 2024-10-01 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Resumption of oral feeding after small intestine surgery is a matter of controversy .Some surgeons advocate early resumption while others don't.early feeding is initiated as soon as the patient recovers from effects of anaesthesia, while late resumption is started after 24-48 hours after surgery.Recent studies and guidelines suggest early feeding. The aim of this study is to compare the early and late resumption of oral feeding.
Eligibility Criteria
Inclusion Criteria: * All patients undergoing small bowel anastomosis for any indication in elective setting * Patients of age between 15 to 65 years. * All genders Exclusion Criteria: * Patient using glucocorticoids or other immunosuppressive drugs * non conseting individuals * Patient having history of gastrectomy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06906289 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 65 Years, studying Enhanced Recovery After Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06906289 currently recruiting?
Yes, NCT06906289 is actively recruiting participants. Contact the research team at saeedkmc2020@gmail.com for enrollment information.
Where is the NCT06906289 trial being conducted?
This trial is being conducted at Peshawar, Pakistan.
Who is sponsoring the NCT06906289 clinical trial?
NCT06906289 is sponsored by Khyber Teaching Hospital. The trial plans to enroll 204 participants.